Le, L., Chi, K., Tyldesley, S., Flibotte, S., Diamond, D.L., Kuzyk, M.A. and Sadar, M.D. (2005) Identification of Serum Amyloid A as a Biomarker to Distinguish Prostate Cancer Patients with Bone Lesions. Clinical Chemistry, 51, 695-707.
https://doi.org/10.1373/clinchem.2004.041087

has been cited by the following article:

• TITLE: A Case Report of the Association Renal AA Amyloidosis and Thyroid Papillary Carcinoma

  AUTHORS: Dione Diomaye Jean Pierre, Jmahri Hind, En-Niya Fatima, Al Hamany Zitouna, Bouattar Tarik, Benamar Loubna, Bayahia Rabéa, Ouzeddoun Naima

  KEYWORDS: Papillary Carcinoma or Thyroid, AA Amyloidosis, Nephrotic Syndrome

  JOURNAL NAME: Open Journal of Nephrology, Vol.8 No.2, June 29, 2018

  ABSTRACT: AA amyloidosis is often secondary to chronic inflammatory diseases but can rarely occur in patients with malignant neoplasms. A 33 years old woman with papillary carcinoma of thyroid was hospitalized in our department of Nephrology for nephrotic syndrome. Renal histology finds AA amyloidosis. To our knowledge, this is the first report of a patient with papillary carcinoma of thyroid and secondary (AA) amyloidosis with amyloid deposition in the kidneys causing nephrotic syndrome.